Glans Resurfacing with Skin Graft for Penile Cancer: A Step-by-Step Video Presentation of the Technique and Review of the Literature.
Journal
BioMed research international
ISSN: 2314-6141
Titre abrégé: Biomed Res Int
Pays: United States
ID NLM: 101600173
Informations de publication
Date de publication:
2019
2019
Historique:
received:
13
02
2019
accepted:
14
04
2019
entrez:
18
7
2019
pubmed:
18
7
2019
medline:
20
12
2019
Statut:
epublish
Résumé
Glans resurfacing has been suggested as a treatment option for the surgical management of superficial penile cancer (Tis, Ta, T1aG1, T1aG2). In this article we describe in detail the glans resurfacing technique with skin graft for penile cancer in a video presentation and we review the current knowledge of the literature. The procedure is described in a stepwise fashion. Initially the patient is circumcised. The glans is marked in quadrants and completely stripped by dissecting and removing the epithelium and subepithelium layer of the glans. Deep spongiosal biopsies are taken to exclude invasion. Each quadrant is sent separately for biopsy. The surface of the graft size needed is estimated. A partial thickness skin graft is harvested from the thigh with a dermatome. The skin graft is then fenestrated. The graft is rolled over the glans and quilted with multiple sutures. A silicone 16F Foley catheter and a suprapubic catheter are placed. The penis is dressed with multiple gauzes and compressed with an elastic band. The patient is discharged the next day. The dressing and Foley catheter are removed in 7 days. The patient continues to use the suprapubic catheter for 7 more days. The patient refrains from any sexual activity for 6 weeks and is closely followed. Glans resurfacing is an emerging new appealing surgical technique that is already a recommendation in the EAU guidelines for the treatment of premalignant and superficial penile lesions. The overall satisfaction rate and recovery of the sexual function are acceptable, and it can be considered an ideal procedure to treat superficial penile cancer.
Identifiants
pubmed: 31312658
doi: 10.1155/2019/5219048
pmc: PMC6595175
doi:
Types de publication
Journal Article
Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
5219048Références
BJU Int. 2004 Dec;94(9):1253-7
pubmed: 15610100
BJU Int. 2006 Sep;98(3):532-6
pubmed: 16925748
Eur Urol. 2007 Sep;52(3):893-8
pubmed: 17275169
Cancer Causes Control. 2009 May;20(4):449-57
pubmed: 19082746
Int J Impot Res. 2009 Sep-Oct;21(5):311-4
pubmed: 19458620
BJU Int. 2011 Mar;107(5):836-840
pubmed: 20840546
Eur Urol. 2011 Jan;59(1):142-7
pubmed: 21050658
World J Urol. 2013 Aug;31(4):861-7
pubmed: 22116602
Indian J Urol. 2013 Apr;29(2):119-23
pubmed: 23956513
Semin Diagn Pathol. 2015 May;32(3):232-7
pubmed: 25662797
Can Urol Assoc J. 2015 Jul-Aug;9(7-8):E423-7
pubmed: 26279710
Cent European J Urol. 2016;69(4):377-383
pubmed: 28127454
J Urol. 2017 Oct;198(4):770-779
pubmed: 28286072